US Medicaid Reform: Legislators Caution CMS Nominee About Coverage Loss
Executive Summary
Seema Verma is closely identified with Medicaid reform but both Republicans and Democrats expressed concern during her Senate confirmation hearing that reforms not translate into loss of insurance coverage.
You may also be interested in...
Orphan Drug Access Threatened By Medicaid Transformation, NORD Says
National Organization for Rare Disorders raises concerns with proposals to limit US federal financial contributions and coverage requirements in Medicaid programs, maintaining states could limit access to orphan drugs.
Medicaid Drug Rebates Will Get Closer Scrutiny From CMS, Verma Pledges
CMS Administrator-nominee Seema Verma promises stronger agency oversight of Medicaid drug rebate program in response to question from Sen. Grassley during Senate confirmation hearing.
Part Of The Solution? PBMs See Opportunities In Medicaid Reform
Amidst a growing chorus of criticism that pharmacy benefit managers are contributing to the problem of high drug costs, PCMA’s Merritt defends the PBM business model and points to its potential for better managing costs in Medicaid.